IT9020295A1 - Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione - Google Patents

Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione

Info

Publication number
IT9020295A1
IT9020295A1 IT020295A IT2029590A IT9020295A1 IT 9020295 A1 IT9020295 A1 IT 9020295A1 IT 020295 A IT020295 A IT 020295A IT 2029590 A IT2029590 A IT 2029590A IT 9020295 A1 IT9020295 A1 IT 9020295A1
Authority
IT
Italy
Prior art keywords
fraction
procedure
ihg4
allergens
pharmaceutical composition
Prior art date
Application number
IT020295A
Other languages
English (en)
Italian (it)
Other versions
IT9020295A0 (it
Inventor
Clothilde Bremard-Oury
Patrick Lambin
Original Assignee
Fond Nat Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Nat Transfusion Sanguine filed Critical Fond Nat Transfusion Sanguine
Publication of IT9020295A0 publication Critical patent/IT9020295A0/it
Publication of IT9020295A1 publication Critical patent/IT9020295A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
IT020295A 1989-05-12 1990-05-14 Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione IT9020295A1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906281A FR2646917A1 (fr) 1989-05-12 1989-05-12 Procede de dosage d'anti-corps igg anti-allergenes specifiques, fraction riche en igg4 obtenue selon ce procede et composition pharmaceutique contenant cette fraction

Publications (2)

Publication Number Publication Date
IT9020295A0 IT9020295A0 (it) 1990-05-14
IT9020295A1 true IT9020295A1 (it) 1990-11-13

Family

ID=9381627

Family Applications (1)

Application Number Title Priority Date Filing Date
IT020295A IT9020295A1 (it) 1989-05-12 1990-05-14 Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione

Country Status (3)

Country Link
FR (1) FR2646917A1 (fr)
IT (1) IT9020295A1 (fr)
WO (1) WO1990013817A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
BRPI0800612A2 (pt) * 2008-01-02 2009-08-25 Fundacao Fapemig método e kit para a quantificação de subclasses de igg humanas especìficas a alérgenos para o acompanhamento da imunoterapia especìfica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228421A (ja) * 1984-04-27 1985-11-13 Shionogi & Co Ltd モノクロ−ナル抗ヒトＩｇＧ抗体およびその製造法
EP0161868B1 (fr) * 1984-05-11 1992-11-04 BioWhittaker, Inc. Dosage fluorimétrique d'IgG4
FR2578425B1 (fr) * 1985-03-07 1988-06-10 Nal Transfusion Sanguine Centr Preparations d'immunoglobulines presentant des titres eleves en anticorps bloquants anti-allergenes, leur preparation et leurs applications pour le traitement d'allergies
JPS61286754A (ja) * 1985-06-12 1986-12-17 Shionogi & Co Ltd モノクロ−ナル抗ヒトＩｇＧ↓４抗体およびその製造法

Also Published As

Publication number Publication date
FR2646917A1 (fr) 1990-11-16
IT9020295A0 (it) 1990-05-14
WO1990013817A1 (fr) 1990-11-15

Similar Documents

Publication Publication Date Title
EP0408859A3 (en) Monoclonal antibodies to activated endothelial cells
ZA908521B (en) Vaccine composition with non-immunosuppressive t cell epitope component
AU7095887A (en) Human gamma interferon-specific receptor protein, antibody against said protein and said antibody and compositions containing said protein and antibody
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
NZ221440A (en) Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
GB2186592B (en) Cross-protective human monoclonal antibody compositions
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
IT9020295A1 (it) Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione
AU7912887A (en) Monoclonal antibodies to fibrin
EP0267601A3 (en) Anti-pci monoclonal antibody
AU591579B2 (en) Antibodies for use in determining human glycoalbumin
AU8168887A (en) Monoclonal antibodies effective in promoting growth
DK138084A (da) Bundet lukkesammenstilling, fortrinsvis til pharmaceutiske beholdere
FI981624A (fi) Koostumukset ja menetelmät Borrelia burgdorferi antigeenien annostelemiseksi
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus
HU896324D0 (en) Peptides binding to antibody
AU5217890A (en) Monoclonal antibodies in vaccine formulations
AU4576689A (en) Peptides which bind to hiv-2 specific antibody
EP0407586A4 (en) Human monoclonal antibody and process for its preparation
DK161389D0 (da) Flaskeemballage
AU6861987A (en) Cross-protective human monoclonal antibody compositions
EP0358468A3 (en) Monoclonal antibody to high molecular weight human epidermal growth factor
GB8811342D0 (en) Expression of antibody heavy & light chain variable domains as active hetero-dimer in myeloma cells
KR900016511U (ko) 화장품 용기

Legal Events

Date Code Title Description
0002 Rejected